南模生物跌3.72% 2021年上市即巅峰募16.5亿元

Core Points - Nanmo Biology's stock price fell by 3.72% to 48.72 yuan on November 3 [1] - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 28, 2021, with an initial offering price of 84.62 yuan per share [1] - The stock is currently in a state of decline, having reached a peak price of 82.00 yuan on its first trading day [1] Fundraising and Financials - Nanmo Biology raised a total of 1.649 billion yuan through its initial public offering (IPO), with a net amount of 1.468 billion yuan after deducting issuance costs [1] - The net fundraising amount exceeded the original plan by 1.068 billion yuan [1] - The company planned to use the funds for various projects, including a biological research base, a genetically modified model resource library, and working capital [1] Issuance Costs - The total issuance costs for the IPO amounted to 181 million yuan, with underwriting fees accounting for 158 million yuan [1]